Metacam

Meloxicam, the active ingredient in Metacam, is a non‑steroidal anti‑inflammatory drug presented as a tablet for oral use. It is employed to relieve pain and reduce inflammation in conditions such as osteoarthritis and rheumatoid arthritis in adult patients and improve joint function under medical supervision.

GNH USA supplies Metacam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across multiple regions. We partner with accredited manufacturers to provide reliable access to essential medicines.

Metacam (meloxicam) is used to manage pain and inflammation associated with several musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: decreases inflammation and joint damage. - Acute musculoskeletal pain: provides rapid analgesia. - Post‑operative pain: helps control postoperative discomfort.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or dyspepsia that may be transient. - Headache: mild to moderate intensity, often resolving without intervention. - Dizziness: transient sensation of light‑headedness, especially when standing quickly. - Edema: mild peripheral swelling, usually of the lower extremities.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening lesions in the stomach or intestines. - Cardiovascular events: increased risk of myocardial infarction or cerebrovascular accident, particularly with long‑term use. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, requiring immediate medical attention.

When prescribing meloxicam, clinicians should consider several safety precautions to minimize risk.

- Renal function: assess baseline kidney function and monitor in patients with renal impairment. - Gastrointestinal risk: avoid in patients with active peptic ulcer disease or a history of serious GI bleeding. - Cardiovascular health: use cautiously in individuals with uncontrolled hypertension or known cardiovascular disease. - Pregnancy and lactation: safety not established; avoid use during pregnancy unless clearly needed. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - High‑dose aspirin or other NSAIDs: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: potential for decreased renal perfusion and electrolyte imbalance.